AstraZeneca Pharmaceuticals (Pty ) Ltd South Africa, South Africa
Clive is currently the Director for Late Stage Oncology within Clinical Development at AstraZeneca. Over the last 6 years, he has held roles across the spectrum of drug development in Oncology from interaction with drug discovery to maximizing brand value of products near patent expiry. Prior to joining AstraZeneca, he trained in surgery leading to accreditation by the Royal College of Surgeons of England, and subsequently gained a Doctorate of Medicine research degree in molecular mechanisms involved in upper gastrointestinal cancer development. Clive also holds an Executive MBA and is accredited as a specialist Pharmaceutical Physician by the UK General Medical Council.
Appearing:
Day Two - Thursday 3 December 2009
13.30
Operationalising a late phase study
• This session will look at the key scientific and commercial challenges in rolling out a late phase programme
